IGF2BP1 and Miyoshi myopathy: Finally, by WB assays, we confirmed that CD138+ plasma cells from MM patients with 1q+ (n = 5) expressed higher levels of IGF2BP1 protein compared with plasma cells from MM patients without 1q+ (n = 4) (Fig. 1F).